Abstract: This invention relates to assemblies, components and method for application of cosmetic products. For example, a cosmetic applicator holder having a base that can be coupled to a makeup applicator and a ring portion for gripping between two fingers. The assemblies are designed to be easy and comfortable to use.

Abstract: An apparatus includes a first guide and a second guide. The first guide includes an arcuate horizontal body portion. A rear surface of the horizontal body portion is configured to closely mate with a front-facing bone structure of an alveolar arch of a patient. The second guide includes a body and a coupling member. The body defines a passageway that is configured to receive a bone reducing instrument. The coupling member is configured to mate with the horizontal body portion of the first guide. The body and the coupling member are configured to position the passageway along a second horizontal plane that is parallel with the first horizontal plane. The coupling member is configured to enable the second guide to move relative to the first guide along the second horizontal plane and thereby guide the bone reducing instrument along the second horizontal plane.

Abstract: The present invention discloses a cavity preparation assembly and a guiding sleeve for immediate implantation in an oral molar region, wherein the guiding sleeve comprises a lower sleeve and an upper sleeve disposed on a top of the lower sleeve, center portions of the upper sleeve and the lower sleeve each has a guiding hole and the guiding holes of the upper sleeve and the lower sleeve are connected, and an axis direction of the guiding hole is a vertical direction; sidewalls of the upper sleeve and the lower sleeve are each provided with a slit passing through the sidewalls, and the slit of the upper sleeve and the slit of the lower sleeve are located on a same side of the cavity preparation guiding sleeve; the upper sleeve is further provided with an installation plate on both sides of the slit, the installation plate is connected to the sidewalls on both sides of the slit of the upper sleeve. The cavity preparation assembly comprises a depth calibration drilling tool and a plurality of guiding sleeves.

Abstract: Described herein are methods for applying a color-altering material to the roots of the hair which reduce the amount of time needed between color applications. The color-altering material is applied horizontally with respect to the hair, and the natural color of the hair is left intact between the color-altering sessions. The methods of this disclosure incorporate the root growth into the overall color pattern of the hair, allowing a user to wait for a longer period of time in between color applications.

Abstract: This invention relates to assemblies, components, and methods for application of cosmetic products. For example, a cosmetic applicator wand in the form of an elongated tool including a region for gripping by a user, an enlarged element optionally including a groove, where the wand can be coupled to an applicator. The assemblies are designed to be easy and comfortable to use.

Abstract: A measuring apparatus for measuring an occlusal distance and/or a space of a missing tooth comprises a connecting rod and a measuring head disposed at an upper end of the connecting rod, the measuring head comprises a first measuring ruler and a second measuring ruler perpendicular to the first measuring ruler, a lower end of the second measuring ruler and one end of the first measuring ruler are connected to the connecting rod. The occlusal distance checking can be performed simply and directly by using the first measuring ruler to directly compare whether it can pass through the occlusion gap in the region to be repaired, the gap of the single missing tooth analysis is performed easily and directly by using the second measuring ruler to directly compare whether it can pass the gap in the measuring region to be repaired.

Abstract: An eyelash shaping implement includes: a curved main body; a tool engagement element; and a set of shaping elements arranged along a surface of the curved main body. An eyelash curler insert includes: a body; and multiple shaping elements protruding from the body. An eyelash shaper tool includes: a movable section; a fixed section; and a shaping implement having: a body coupled to the movable section; and at least one shaping element protruding from the body. Shaping elements include spherical protuberances, undulating linear protuberances, and tapered surfaces.

Abstract: The invention relates to a dental prosthesis comprising a prosthesis base and teeth which are attached in or to the prosthesis base (14), wherein the prosthesis base (14) comprises a ventilation element, in particular a ventilation valve (12).

Abstract: An extended-release antibiotic composition comprising at least one antibiotic, and greater than 50 weight percent, based on the total weight of the composition, of a polymer component, wherein said polymer component comprises at least one pharmaceutically acceptable hydrophilic polymer, and said polymer component has a viscosity of less than about 50 cps.

Abstract: This invention relates to biodurable, reticulated elastomeric matrices that are resiliently-compressible, their manufacture and uses including uses for implantable devices into or for topical treatment of patients, such as humans and other animals, for therapeutic, nutritional, or other useful purposes.

Abstract: A polymer of siloxanes as flexibility monomers and strength monomers is provided. It is also provided a polymer blend that contains a polymer formed of siloxane monomers and strength monomers and another biocompatible polymer. The biocompatible polymer or polymer blend described herein and optionally a bioactive agent can form a coating on an implantable device such as a drug-delivery stent. The implantable device can be used for treating or preventing a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

Abstract: The present invention relates to a novel modified release pharmaceutical composition comprising the coated capsule body, coated or uncoated capsule cap, at least one tablet and granulate comprising active substance.

Abstract: The self-inflating article of the present invention contains a self-inflating personal care article contains, an inflatable bladder containing a substrate, at least one rupturable reservoir, a cleansing composition wherein said rupturable reservoir is positioned within the sack of the inflatable bladder. The self-inflating article surprisingly provides effective cleansing benefits to the skin and hair in a convenient, inexpensive, and sanitary manner.

Abstract: A medical device having a hydration inhibitor for controlled delivery of a beneficial agent and methods of manufacturing of the same. The medical device includes an interventional component loaded with a beneficial agent having a first Log P value, the beneficial agent being associated with a hydration inhibitor to control the elution rate of at least part of the beneficial agent, the hydration inhibitor having a second Log P value which is greater than the first Log P value.

Abstract: Microspheres to be implanted into a patient are metered and mixed with fluids, cells, or tissues withdrawn from the patient's own body, and reinserted into the patient's body to achieve augmentation, repair or other treatment of the patient's tissue.

Abstract: A vasoocclusive microcoil for therapeutic treatment of a patient's vasculature includes a surface with a plurality of voids or pores therein, and a therapeutic or bioactive material disposed within the plurality of voids or pores. The therapeutic or bioactive material within the plurality of voids or pores operates to accelerate a healing process in the patient's vasculature when the microcoil is introduced into the patient's vasculature.

Abstract: The invention relates to a coating material for protection against microorganism invasion on surfaces which are exposed to the effects of damp or water. The coating material has either a pH-value of at least 11.0 or is provide with a base material for the coating whereby the pH-value is at least 11. The coating material is characterized in that it contains a biocide which bonds to solid particles in a carrier material and is released in a delayed manner therefrom.

Abstract: The invention provides a rapidly disintegrating tablet comprising an active ingredient, a water soluble, directly compressible carbohydrate, and a water soluble, directly compressible filler. Also provided is a method of producing a rapidly disintegrating tablet, which method comprises wet granulating a mixture comprising a directly compressible, water soluble carbohydrate, a directly compressible, water insoluble filler, a beneficial ingredient, and a solvent, and compressing the granulate to produce the tablet.

Abstract: A method of enhancing the drug release rate from a composite material. The composite material includes a synthetic, bioabsorbable polymer matrix and a drug particle phase dispersed therein. The release rate of the drug from the polymer matrix is enhanced by orienting the composite material. The drug release rate of the oriented composite material is greater than the drug release rate from an otherwise comparable non-oriented composite material.

Abstract: A specific dosage regimen of buprenorphine achieves pain relief from painful episodes due to sickle cell disease. The dosage regimen comprises administering to a patient in need of pain relief from sickle cell disease at least one BTDS transdermal patch. Alternatively, the dosing regimen comprises administering to the patient (1) a first buprenorphine-containing transdermal dosage form for a first dosing period; (2) administering to the patient a second buprenorphine-containing transdermal dosage form for a second dosing period, where the second dosage form comprises the same dosage of buprenorphine as, or a greater dosage of buprenorphine than, the first dosage form; and (3) administering to the patient a third buprenorphine-containing transdermal dosage form for a third dosing period, where the third dosage form comprises a greater dosage of buprenorphine than the second dosage form.